Silvia Salerno

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Structure Activity Relationship

Top Venues

Molecules (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Elisabetta Barresi, Emma Baglini, Valeria Poggetti, Jacopo Castagnoli, Doralice Giorgini, Silvia Salerno, Sabrina Taliani, Federico Da Settimo
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents. Molecules (Basel, Switzerland) 29 (9) (2024)
Elisabetta Barresi, Emma Baglini, Valeria Poggetti, Jacopo Castagnoli, Doralice Giorgini, Silvia Salerno, Sabrina Taliani, Federico Da Settimo
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents. Molecules (Basel, Switzerland) 29 (9) (2024)
Silvia Salerno, Monica Viviano, Emma Baglini, Valeria Poggetti, Doralice Giorgini, Jacopo Castagnoli, Elisabetta Barresi, Sabrina Castellano, Federico Da Settimo, Sabrina Taliani
TSPO Radioligands for Neuroinflammation: An Overview. Molecules (Basel, Switzerland) 29 (17) (2024)
Silvia Salerno, Elisabetta Barresi, Emma Baglini, Valeria Poggetti, Federico Da Settimo, Sabrina Taliani
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents. Molecules (Basel, Switzerland) 28 (6) (2023)
Silvia Salerno, Elisabetta Barresi, Emma Baglini, Valeria Poggetti, Federico Da Settimo, Sabrina Taliani
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents. Molecules (Basel, Switzerland) 28 (6) (2023)
Elisabetta Barresi, Marco Robello, Emma Baglini, Valeria Poggetti, Monica Viviano, Silvia Salerno, Federico Da Settimo, Sabrina Taliani
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Silvia Salerno, Elisabetta Barresi, Emma Baglini, Valeria Poggetti, Federico Da Settimo, Sabrina Taliani
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents. Molecules (Basel, Switzerland) 28 (6) (2023)
Marco Robello, Silvia Salerno, Elisabetta Barresi, Paola Orlandi, Francesca Vaglini, Marta Banchi, Francesca Simorini, Emma Baglini, Valeria Poggetti, Sabrina Taliani, Federico Da Settimo, Guido Bocci
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: Synthesis and pharmacological effects. Archiv der Pharmazie 355 (11) (2022)
Valeria Poggetti, Silvia Salerno, Emma Baglini, Elisabetta Barresi, Federico Da Settimo, Sabrina Taliani
Carbonic Anhydrase Activators for Neurodegeneration: An Overview. Molecules (Basel, Switzerland) 27 (8) (2022)
Silvia Salerno, Elisabetta Barresi, Emma Baglini, Valeria Poggetti, Sabrina Taliani, Federico Da Settimo
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview. Biomedicines 10 (11) (2022)
Elisabetta Barresi, Chiara Giacomelli, Laura Marchetti, Emma Baglini, Silvia Salerno, Giovanni Greco, Federico Da Settimo, Claudia Martini, Maria Letizia Trincavelli, Sabrina Taliani
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
Emma Baglini, Rahul Ravichandran, Emanuela Berrino, Silvia Salerno, Elisabetta Barresi, Anna Maria Marini, Monica Viviano, Sabrina Castellano, Federico Da Settimo, Claudiu T Supuran, Sandro Cosconati, Sabrina Taliani
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
Elisabetta Barresi, Rahul Ravichandran, Lorenzo Germelli, Andrea Ageli, Emma Baglini, Silvia Salerno, Anna Maria Marini, Barbara Costa, Eleonora Da Pozzo, Claudia Martini, Federico Da Settimo, Claudiu T Supuran, Sandro Cosconati, Sabrina Taliani
Carbonic anhydrase activation profile of indole-based derivatives. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)